(Q36640460)

15 August 2017

1 reference

title

Gut-brain axis: regulation of glucose metabolism (English)

1 reference

15 August 2017

0 references

Heijboer AC

1

1 reference

15 August 2017

Pijl H

2

1 reference

15 August 2017

Van den Hoek AM

3

1 reference

15 August 2017

Havekes LM

4

1 reference

15 August 2017

Romijn JA

5

1 reference

15 August 2017

Corssmit EP

6

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Journal of Neuroendocrinology

15 August 2017

published in

1 reference

15 August 2017

volume

18

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

883-894

1 reference

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Peptide YY: a potential therapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Diabetes, obesity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Neuropeptides, food intake and body weight regulation: a hypothalamic focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Anatomical and functional evidence for a neural hypothalamic-testicular pathway that is independent of the pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The central melanocortin system can directly regulate serum insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

A frameshift mutation in MC4R associated with dominantly inherited human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

A frameshift mutation in human MC4R is associated with a dominant form of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The gut and regulation of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

To eat or not to eat - how the gut talks to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Gut hormones and the control of appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Appetite regulation: from the gut to the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Gastrointestinal hormones and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin enhances appetite and increases food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Action of MT-II on ghrelin-induced feeding in the paraventricular nucleus of the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

A receptor in pituitary and hypothalamus that functions in growth hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Identification of cholecystokinin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Cholecystokinin and gastrin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Vagal mediation of the cholecystokinin satiety effect in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Peptides and the control of meal size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Claude Bernard: primer of the second biomedical revolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Central nervous determination of food storage--a daily switch from conservation to expenditure: implications for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Role of brain insulin receptor in control of body weight and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Our journey with neuropeptide Y: effects on ingestive behaviors and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Central melanocortin receptors regulate insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin stimulates gastric acid secretion and motility in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Dose-dependent inhibition by ghrelin of insulin secretion in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Circulating ghrelin levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Cross-sectional and prospective relationships of fasting plasma ghrelin concentrations with anthropometric measures in pima Indian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin suppression in overweight children: a manifestation of insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Plasma ghrelin and desacyl ghrelin concentrations in renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Synthesis, secretion and biological actions of the glucagon-like peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Physiology of GIP--a lesson from GIP receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Characterization of blood-brain barrier permeability to PYY3-36 in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The role of gastrointestinal vagal afferents in the control of food intake: current prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Neural connections between the hypothalamus and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Cholecystokinin Metabolism in Man and Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2006.01492.X

10.1111/J.1365-2826.2006.01492.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference